Rådmark O, Werz O, Steinhilber D, Samuelsson B. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim Biophys Acta. 2015;1851:331–9.
PubMed Article CAS Google Scholar
Haeggström JZ, Funk CD. Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem Rev. 2011;111:5866–98.
PubMed Article CAS Google Scholar
Roos J, Oancea C, Heinssmann M, Khan D, Held H, Kahnt AS, et al. 5-Lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia. Cancer Res. 2014;74:5244–55.
CAS PubMed Article Google Scholar
Chen Y, Hu Y, Zhang H, Peng C, Li S. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet. 2009;41:783–92.
CAS PubMed PubMed Central Article Google Scholar
Ma D, Liu P, Wang P, Zhou Z, Fang Q, Wang J. PKC-β/Alox5 axis activation promotes Bcr-Abl-independent TKI-resistance in chronic myeloid leukemia. J Cell Physiol. 2021;236:6312–27.
CAS PubMed Article Google Scholar
Cheng J-H, Zhang W-J, Zhu J-F, Di C, Song K-D, Qiang P, et al. CaMKIIγ regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-κB pathway. Int J Lab Hematol. 2021;43:699–706.
Nielsen CK, Ohd JF, Wikström K, Massoumi R, Paruchuri S, Juhas M, et al. The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer. Adv Exp Med Biol. 2003;525:201–4.
CAS PubMed Article Google Scholar
Barresi V, Grosso M, Vitarelli E, Tuccari G, Barresi G. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage. Dis Colon Rectum. 2007;50:1576–84.
Melstrom LG, Bentrem DJ, Salabat MR, Kennedy TJ, Ding X-Z, Strouch M, et al. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model. Clin Cancer Res. 2008;14:6525–30.
CAS PubMed Article Google Scholar
Wasilewicz MP, Kołodziej B, Bojułko T, Kaczmarczyk M, Sulzyc-Bielicka V, Bielicki D, et al. Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. Int J Colorectal Dis. 2010;25:1079–85.
PubMed PubMed Central Article Google Scholar
Bai C-Y, Zhang J-Y, Shi T-W, Bai Y-Q, Wu B-L, Du Z-P, et al. Association between 5-lipoxygenase expression, and malignant behaviors and poor prognosis in esophageal squamous cell carcinoma. Oncol Lett. 2018;15:9353–60.
PubMed PubMed Central Google Scholar
Hoque A, Lippman SM, Wu T-T, Xu Y, Liang ZD, Swisher S, et al. Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. Carcinogenesis 2005;26:785–91.
CAS PubMed Article Google Scholar
Chen X, Wang S, Wu N, Sood S, Wang P, Jin Z, et al. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin Cancer Res. 2004;10:6703–9.
CAS PubMed Article Google Scholar
Xingfu W, Lifeng Z, Yupeng C, Xueyong L, Wei L, Yinghao Y, et al. Cytoplasmic 5-Lipoxygenase staining is a highly sensitive marker of human tumors of the choroid plexus. Am J Clin Pathol. 2015;144:295–304.
PubMed Article CAS Google Scholar
Matsuyama M, Yoshimura R, Mitsuhashi M, Hase T, Tsuchida K, Takemoto Y, et al. Expression of lipoxygenase in human prostate cancer and growth reduction by its inhibitors. Int J Oncol. 2004;24:821–7.
Gupta S, Srivastava M, Ahmad N, Sakamoto K, Bostwick DG, Mukhtar H. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma. Cancer 2001;91:737–43.
CAS PubMed Article Google Scholar
Jiang WG, Douglas-Jones A, Mansel RE. Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Ess Fat Acids. 2003;69:275–81.
Kennedy BM, Harris RE. Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer. Inflammopharmacology 2018;26:909–3.
Derish PA, Sokal RR. A classification of European populations based on gene frequencies and cranial measurements: a map-quadrat approach. Hum Biol. 1988;60:801–24.
Avis IM, Jett M, Boyle T, Vos MD, Moody T, Treston AM, et al. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest. 1996;97:806–13.
CAS PubMed PubMed Central Article Google Scholar
Xu X-M, Deng J-J, Yuan G-J, Yang F, Guo H-T, Xiang M, et al. 5-Lipoxygenase contributes to the progression of hepatocellular carcinoma. Mol Med Rep. 2011;4:1195–200.
Yoshimura R, Matsuyama M, Tsuchida K, Kawahito Y, Sano H, Nakatani T. Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J Urol. 2003;170:1994–9.
CAS PubMed Article Google Scholar
Hennig R, Ding X-Z, Tong W-G, Schneider MB, Standop J, Friess H, et al. 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol. 2002;161:421–8.
CAS PubMed PubMed Central Article Google Scholar
Ohd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H, Sjölander A. Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 2003;124:57–70.
CAS PubMed Article Google Scholar
Sun Z, Sood S, Li N, Ramji D, Yang P, Newman RA, et al. Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenzaanthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors. Carcinogenesis 2006;27:1902–8.
CAS PubMed Article Google Scholar
Jiang WG, Douglas-Jones AG, Mansel RE. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Prostaglandins Leukot Ess Fat Acids. 2006;74:125–34.
Runarsson G, Feltenmark S, Forsell PKA, Sjöberg J, Björkholm M, Claesson H-E. The expression of cytosolic phospholipase A2 and biosynthesis of leukotriene B4 in acute myeloid leukemia cells. Eur J Haematol. 2007;79:468–76.
CAS PubMed Article Google Scholar
Chen X, Sood S, Yang CS, Li N, Sun Z. Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention. Curr Cancer Drug Targets. 2006;6:613–22.
CAS PubMed Article Google Scholar
Boado RJ, Pardridge WM, Vinters HV, Black KL. Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family. Proc Natl Acad Sci USA. 1992;89:9044–8.
CAS PubMed PubMed Central Article Google Scholar
Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 1999;59:2223–8.
Avis I, Hong SH, Martinez A, Moody T, Choi YH, Trepel J, et al. Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. FASEB J. 2001;15:2007–9.
CAS PubMed Article Google Scholar
Hennig R, Ding X-Z, Adrian TE. On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol. 2004;19:999–1011.
Romano M, Catalano A, Nutini M, D’Urbano E, Crescenzi C, Claria J, et al. 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. FASEB J. 2001;15:2326–36.
CAS PubMed Article Google Scholar
Roos J, Kühn B, Fettel J, Maucher IV, Ruthardt M, Kahnt A et al. Role of Lipoxygenases in pathogenesis of cancer. In: Steinhilber D, editor. Lipoxygenases in Inflammation. Cham: Springer International Publishing. 2016. p. 131–57.
Tong W-G, Ding X-Z, Talamonti MS, Bell RH, Adrian TE. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways. Biochem Biophys Res Commun. 2005;335:949–56.
CAS PubMed Article Google Scholar
Ding XZ, Iversen P, Cluck MW, Knezetic JA, Adrian TE. Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun. 1999;261:218–23.
CAS PubMed Article Google Scholar
Tsukada T, Nakashima K, Shirakawa S. Arachidonate 5-lipoxygenase inhibitors show potent antiproliferative effects on human leukemia cell lines. Biochem Biophys Res Commun. 1986;140:832–6.
CAS PubMed Article Google Scholar
Shimakura S, Boland CR. Eicosanoid production by the human gastric cancer cell line AGS and its relation to cell growth. Cancer Res. 1992;52:1744–9.
Ghosh J, Myers CE. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA. 1998;95:13182–7.
留言 (0)